PAQR9-AS1

Across TCGA pan-cancer cohorts, PAQR9-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated PAQR9-AS1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PAQR9-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PAQR9-AS1 expression acts as an unfavorable survival marker, although some lineages such as PRAD show a favorable association.

LUAD, MESO, and THCA are the cancer types where PAQR9-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.587	0.723	<.001	114	view →
MESO	OS	Tertile	All	0.397	0.597	.007	67	view →
THCA	OS	Tertile	All	0.969	0.997	<.001	58	view →
BLCA	DFS	Median	II,III,IV	0.548	0.681	.004	48	view →
TGCT	DFS	Median	All	0.711	0.889	.006	18	view →
DLBC	OS	Tertile	II,III,IV	0.560	1.000	.021	16	view →
READ	DFS	Tertile	II,III,IV	0.215	0.634	.006	15	view →
ACC	DFS	Median	All	0.575	0.865	.008	13	view →
SKCM	DFS	Tertile	IV	0.059	0.513	.018	10	view →
THYM	DFS	Tertile	IV	0.407	1.000	.026	9	view →
SARC	OS	Quartile	All	0.779	0.860	.010	7	view →
KIRP	DFS	Median	IV	0.039	0.526	.016	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

PAQR9-AS1–LUAD (OS)

Open the LUAD breakdown →